BALAXI PHARMACEUTICALS LIMITED Capital Reinvestment Ratio
BALAXI PHARMACEUTICALS LIMITED capital reinvestment ratio. BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Capital Reinvestment Ratio of 0.83x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs149.66 Million) in capital expenditures (Rs123.88 Million). See cash generation quality of BALAXI PHARMACEUTICALS LIMITED to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BALAXI PHARMACEUTICALS LIMITED (2015–2024)
Capital reinvestment ratio of BALAXI PHARMACEUTICALS LIMITED from 2015 to 2024. This chart tracks BALAXI PHARMACEUTICALS LIMITED's Capital Reinvestment Ratio across 5 annual periods. See BALAXI FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
BALAXI PHARMACEUTICALS LIMITED Capital Reinvestment Ratio by Year (2015–2024)
BALAXI PHARMACEUTICALS LIMITED capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see cash flow conversion of BALAXI PHARMACEUTICALS LIMITED.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | Rs48.66 Million | Rs15.69 Million | ▼ -86.9% |
| 2023 | 2.47x | Rs60.75 Million | Rs149.80 Million | ▲ +207.9% |
| 2022 | 0.80x | Rs341.44 Million | Rs273.44 Million | ▼ -99.9% |
| 2021 | 824.65x | Rs31.00K | Rs25.56 Million | ▲ +5861379.5% |
| 2015 | 0.01x | Rs2.11 Million | Rs29.72K | — |